Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00204932 · ClinicalTrials.gov registry record · Phase 2
Effects of CLA Supplements on Body Weight and Fat Oxidation
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 53
- Enrollment target
NCT00204932 is a Phase 2 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 53 participants.
The verdict
NCT00204932, a Phase 2 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 53 participants
- Enrollment target
Study Summary
Conjugated linoleic acid (CLA) is form of fat found in dairy foods, beef and other natural sources. When given to small animals, decreases of body fat have been noted.. Although weight loss is the best treatment for overweight and obesity, it is difficult to maintain the loss in the long term. Because of this, treatment emphasis has turned to small weight losses obtained through non-restrictive diets and prevention of weight regain. This is a study to determine if 6 months of consumption a purified form of CLA will result in greater loss of body fat than control and to determine whether CLA consumption increases total fat oxidation, which would help explain why the weight loss occurs.
Interventions
- DRUG conjugated linoleic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2004-07 |
| Est. Completion | 2005-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00204932
The ClinicalTrials.gov registry entry for NCT00204932 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which conjugated linoleic acid is the first listed.
NCT00204932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00204932 about?
NCT00204932 is a clinical study titled "Effects of CLA Supplements on Body Weight and Fat Oxidation". Conjugated linoleic acid (CLA) is form of fat found in dairy foods, beef and other natural sources. When given to small animals, decreases of body fat have been noted.. Although weight loss is the best treatment for overweight and obesity, it is difficult to maintain the loss in the long term. Becau...
What is the current status of trial NCT00204932?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 53 participants. The study started on 2004-07. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00204932?
The interventions under investigation include: conjugated linoleic acid (DRUG).
Who is sponsoring clinical trial NCT00204932?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.